Abpro Holdings (ABPO) Enterprise Value (2022 - 2026)
Abpro Holdings' (ABPO) quarterly Enterprise Value came in at -$4.9 million in Q1 2026, down 468.22% YoY from $1.3 million in Q1 2025, and down 1141.54% on a QoQ basis from $467000.0 in Q4 2025.
Abpro Holdings (ABPO) Enterprise Value (2022 - 2026) Analysis & Trends
Abpro Holdings (ABPO) has 5 years of Enterprise Value data on file, last reported at -$4.9 million in Q1 2026.
- Quarterly Enterprise Value fell 468.22% year-over-year to -$4.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.9 million (down 468.22% YoY) and the FY2025 annual result came in at $467000.0, up 69.82% from the prior year.
- Enterprise Value fell to -$4.9 million in Q1 2026, from $467000.0 in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of $467000.0 in Q4 2025 to a low of -$4.9 million in Q1 2026.
- A 5-year average of -$650456.6 and a median of -$312896.5 in 2022 frame the typical range for Enterprise Value.
- The widest YoY moves for Enterprise Value: up 19200.0% in 2025, down 632.67% in 2025.
- Tracing ABPO's Enterprise Value over 5 years: stood at -$392446.0 in 2022, then declined by 14.67% to -$450000.0 in 2023, then soared by 161.11% to $275000.0 in 2024, then jumped by 69.82% to $467000.0 in 2025, then plunged by 1141.54% to -$4.9 million in 2026.
- The last three Enterprise Value figures came in at -$4.9 million (Q1 2026), $467000.0 (Q4 2025), and $191000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -3.31 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -18.39 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -1.16 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.12 Bn |
| 10 | Abpro Holdings | 1.14 Mn | 1.14 Mn | - | -3.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.86 Mn |
| Dec 31, 2025 | 467,000.00 |
| Sep 30, 2025 | 191,000.00 |
| Jun 30, 2025 | -1.48 Mn |
| Mar 31, 2025 | -856,000.00 |
| Dec 31, 2024 | 275,000.00 |
| Sep 30, 2024 | -1,000.00 |
| Jun 30, 2024 | -202,000.00 |
| Mar 31, 2024 | -220,000.00 |
| Dec 31, 2023 | -450,000.00 |
| Sep 30, 2023 | -948,153.00 |
| Mar 31, 2023 | -295,224.00 |
| Dec 31, 2022 | -392,446.00 |
| Mar 31, 2022 | -330,569.00 |